Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Low Cardiac Output Syndrome

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with…
BACKGROUND The calcium sensitizer levosimendan has been used in cardiac surgery for the treatment of postoperative low cardiac… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Highly Cited
2012
Highly Cited
2012
Comparison of Maximum Vasoactive Inotropic Score and Low Cardiac Output Syndrome As Markers of Early Postoperative Outcomes After Neonatal Cardiac Surgery
Low cardiac output syndrome (LCOS) and maximum vasoactive inotropic score (VIS) have been used as surrogate markers for early… Expand
  • table 1
  • table 3
  • figure 1
  • table 2
  • figure 2
Highly Cited
2011
Highly Cited
2011
Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years.
BACKGROUND Postoperative low cardiac output syndrome (LCOS) is associated with high morbidity and mortality after coronary artery… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2008
Highly Cited
2008
[The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
INTRODUCTION AND OBJECTIVES The use of levosimendan to treat postoperative low cardiac output syndrome (LCOS) has been studied in… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 5
Review
2007
Review
2007
Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post‐operative cardiac surgery patients in Germany: results from a postal survey
Background:  In Germany, more than 100,000 patients are monitored and treated in 80 intensive care units (ICUs) following cardiac… Expand
Highly Cited
2007
Highly Cited
2007
Preliminary experience with inhaled milrinone in cardiac surgery.
BACKGROUND Inhaled administration of milrinone reduces pulmonary artery pressure. Pulmonary hypertension (PH) and right heart… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2005
Review
2005
Predictors of Low Cardiac Output Syndrome After Isolated Aortic Valve Surgery
Background—Low cardiac output syndrome (LCOS), defined as the need for postoperative intraaortic balloon pump or inotropic… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Highly Cited
2003
Highly Cited
2003
Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease
Background—Low cardiac output syndrome (LCOS), affecting up to 25% of neonates and young children after cardiac surgery… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2002
Highly Cited
2002
Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics.
BACKGROUND Many pediatric patients undergoing cardiac surgery involving cardiopulmonary bypass have a predictable fall in the… Expand
  • figure 1
1987
1987
Preliminary results with amrinone in perioperative low cardiac output syndrome.
The hemodynamic parameters of 24 cardiosurgical patients with low cardiac output syndrome (LCOS) after weaning from bypass were… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE